Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation

<div>Effects of siRNA-IL-18 on the donor tracheal occlusion rates of mouse heterotopic tracheal transplantation model (hematoxylin-eosin staining). (a) siRNA-IL-18 group (×40), (b) siRNA-IL-18 group (×400), (c) empty vector group (×40), (d) empty vector group (×400), (e) blank control group (×40), and (f) blank control group (×400).</div>

Disease Markers

fig2

Figure 2

Figure 2: Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation 

Figure 2 | Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation 